Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_assertion type Assertion NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_head.
- NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_assertion description "[Our results suggest that Brenner tumors and TCCs follow different tumorigenic pathways, whereas borderline and malignant Brenner tumors are low-grade neoplasms with activation of the PI3K/AKT pathway through EGFR, TCCs are high-grade tumors that have p53 mutations and p16 and p53 protein overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_provenance.
- NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_assertion evidence source_evidence_literature NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_provenance.
- NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_assertion SIO_000772 19033864 NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_provenance.
- NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_assertion wasDerivedFrom befree-20150227 NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_provenance.
- NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_assertion wasGeneratedBy ECO_0000203 NP304401.RAZytmuBAopIByZrb-VwyPbqyCWDIOERuIyxRA11YsFxc130_provenance.